Skip to main content
SpringerLink
Log in

Thyroid hormones and heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Heart failure is a major health problem and its relationship to thyroid dysfunction has been increasingly investigated in recent years. Since it has been demonstrated that thyroid hormones (TH) and mainly T3 have cardioprotective effects, it is easy to understand that in the scenario of thyroid disorder, cardiac function may be damaged, and inversely in cardiac dysfunction thyroid dysregulation may be seen. The increase in plasma TH produces a clear neurohormonal activation which impacts negatively on cardiac function. In hypothyroidism, and in addition to extracardiac dysfunction, myocardial and vascular remodelling is altered and they contribute to cardiac failure. Abnormal low plasma TSH has also been shown to be a risk factor for developing HF in several recent studies, and they suggest that TSH is an independent predictor of clinical outcome including death and cardiac hospitalizations. Therefore, physicians should consider all these concepts when managing a patient with heart failure, not only for a clear diagnosis, but also for better and accurate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Konstam MA (2000) Progress in heart failure management? Lessons from the real world. Circulation 102:1076–1078

    Article  CAS  PubMed  Google Scholar 

  2. Klein I (2003) Thyroid hormone and cardiac contractility. Am J Cardiol 91:1331–1332

    Article  PubMed  Google Scholar 

  3. Cheng SY, Leonard JL, Davis PJ (2010) (Molecular aspects of thyroid hormone actions. Endocr Rev 31:139–170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Vicinanza R, Cappotelli G, Malacrino C, Nardo T, Buchetti B, Lenti L et al (2013) Oxidized low density liporoteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid 23:231–238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Schmidt Ott UM, Acheim DD (2006) Thyroid hormone and heart failure. Cuur Heart Fail Rep 3:114–119

    Article  CAS  Google Scholar 

  6. Bauer DC (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466

    Article  PubMed  Google Scholar 

  7. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP et al (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure: the Cardiovascular Health Study. J Am Coll Cardiol 52:1152–1159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR et al (2012) Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126:1040–1049

    Article  CAS  PubMed  Google Scholar 

  9. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for aterosclerosis and myocardial infarction in elderly women. The Rotterdam study. Ann Intern Med 132:270–278

    Article  CAS  PubMed  Google Scholar 

  10. Chen S, Shauer A, Zwas DR, Lotan C, Keren A, Gotsman I (2014) The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail 16:217–226

    Article  CAS  PubMed  Google Scholar 

  11. Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Johnson GW, Poole JE et al (2013) Thyroid function in heart failure and impact on mortality. JACC Heart Fail 1:48–55

    Article  PubMed  PubMed Central  Google Scholar 

  12. Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M et al (2003) Low-T3 syndrome. A strong prognostic predictor of death in patients with heart disease. Circulation 107:708–713

    Article  PubMed  Google Scholar 

  13. Pingitore A, Landi P, Taddei MC, Ripoli A, L’Abbate A, Iervasi G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118:132–136

    Article  CAS  PubMed  Google Scholar 

  14. Pimentel RC, Cardoso GP, Escosteguy CC, Abreu LM (2006) Thyroid hormone profile in acute coronary syndromes. Arq Bras Cardiol 87:688–694

    CAS  PubMed  Google Scholar 

  15. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P et al (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172:799–809

    Article  CAS  PubMed  Google Scholar 

  16. Laragh JH, Sealey JE (2003) Relevance of the plasma renin control system that regulates blood pressure and sodium level for correcting treating hypertension and ALLHAT. Am J Hypertens 16(407):411

    Google Scholar 

  17. Duntas LH (2002) Thyroid disease and lipids. Thyroid 12:287–293

    Article  CAS  PubMed  Google Scholar 

  18. Bamashmoos L, Al-Nuzaily B, Al-Meeri A, Ali F (2013) Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. SpringerPlus 2:423

    Article  PubMed  PubMed Central  Google Scholar 

  19. Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersi WM (2001) Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol 54:197–204

    Article  CAS  Google Scholar 

  20. Deveroux D, Teweld SZ (2014) Endocrine and metabolic emergencies. Hypertiroydism and thyrotoxicosis. Emerg Med Clin North Am 32(2):VII–X

  21. Yamashita Y, Iguchi M, Nakatani R, Usui T, Takagi D, Hamatani Y et al (2015) Thyroid storm with heart failure treated with a short-acting beta-adrenoreceptor blocker, landiolol hydrochloride. Intern Med 54:1633–1637

    Article  PubMed  Google Scholar 

  22. Gerdes AM, Iervasi G (2010) Thyroid replacement therapy and heart failure. Circulation 122:385–393

    Article  PubMed  Google Scholar 

  23. Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D et al (2008) Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93:1351–1358

    Article  CAS  PubMed  Google Scholar 

  24. Pantos C, Mourouzis I, Cokkinos DV (2011) New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev 16(1):79–96

    Article  CAS  PubMed  Google Scholar 

  25. Cokkinos DV (2014) The mechanisms of cell death. In: Cokkinos DV (ed) Introduction to translational cardiovascular research. Springer, Cham, pp 253–278

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DAMIC/Fundación Rusculleda, Cordoba National University, Av. Colon 2057, Córdoba, 5000, Argentina

    Felipe Martinez

Authors
  1. Felipe Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Felipe Martinez.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martinez, F. Thyroid hormones and heart failure. Heart Fail Rev 21, 361–364 (2016). https://doi.org/10.1007/s10741-016-9556-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-016-9556-5

Keywords

Search

Navigation